Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L C Ketelaars

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|May 16, 2022
<i>In Silico</i> Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell RecognitionOlga I Isaeva, Steven L C Ketelaars, Pia Kvistborg
Cell Reports|December 18, 2025
Aneuploidy patterns in colorectal cancerIrene C Zaalberg, Steven L C Ketelaars, Henriette C Jodal, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Nature Communications|May 11, 2021
Identification and characterization of a SARS-CoV-2 specific CD8<sup>+</sup> T cell response with immunodominant featuresAnastasia Gangaev, Steven L C Ketelaars, Olga I Isaeva, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2026
Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patientsIngrid A Franken, Steven L C Ketelaars, Carmen Rubio-Alarcón, et al.
Journal for Immunotherapy of Cancer|December 2, 2020
Comprehensive analysis of cutaneous and uveal melanoma liver metastasesEsmee P Hoefsmit, Elisa A Rozeman, Trieu My Van, et al.
Nature Medicine|May 16, 2019
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Nature Medicine|June 19, 2019
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
The British Journal of Surgery|January 9, 2026
Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 studyCarmen Rubio-Alarcón, Andrew Georgiadis, Ingrid A Franken, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|May 16, 2022
<i>In Silico</i> Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell RecognitionOlga I Isaeva, Steven L C Ketelaars, Pia Kvistborg
Cell Reports|December 18, 2025
Aneuploidy patterns in colorectal cancerIrene C Zaalberg, Steven L C Ketelaars, Henriette C Jodal, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Nature Communications|May 11, 2021
Identification and characterization of a SARS-CoV-2 specific CD8<sup>+</sup> T cell response with immunodominant featuresAnastasia Gangaev, Steven L C Ketelaars, Olga I Isaeva, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2026
Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patientsIngrid A Franken, Steven L C Ketelaars, Carmen Rubio-Alarcón, et al.
Journal for Immunotherapy of Cancer|December 2, 2020
Comprehensive analysis of cutaneous and uveal melanoma liver metastasesEsmee P Hoefsmit, Elisa A Rozeman, Trieu My Van, et al.
Nature Medicine|May 16, 2019
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Nature Medicine|June 19, 2019
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
The British Journal of Surgery|January 9, 2026
Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 studyCarmen Rubio-Alarcón, Andrew Georgiadis, Ingrid A Franken, et al.
Pageof 2